-Advertisement-
-Advertisement-
Metabolic
Newborn screening for rare disease improves outcomes
The implementation of maple syrup urine disease (MSUD) newborn screening (NBS) is a crucial advancement in the management of this rare disease, according to a study, which found that by enabling early detection, a NBS screening program significantly increased the likelihood of survival for affected infants. The study, which utilized...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Contact
© 2024 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved